In Phase C, members will get ABBV-744 and oral navitoclax. In Section D, members will obtain ABBV-744 and ruxolitinib. Individuals will obtain treatment right until disease progression or the participants are unable to tolerate the study drugs. 88 These preclinical studies supply paradigms for long term clinical trials in AML, https://howdoesabbv-744workincanc24689.bloggerbags.com/37315321/a-simple-key-for-abbv-744-for-targeted-cancer-therapy-treatment-unveiled